Biological therapies: a long way on from Jenner
Giving monoclonal antibodies to healthy volunteers in phase 1 trials: is it safe?
A pharmacologic perspective on newly emerging T-cell manipulation technologies
A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus
A regulatory perspective of clinical trial applications for biological products with particular emphasis on Advanced Therapy Medicinal Products (ATMPs)
Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing
A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting
Novel antibodies targeting immune regulatory checkpoints for cancer therapy
Drug-conjugated antibodies for the treatment of cancer
How biologics targeting the IL-1 system are being considered for the treatment of type 2 diabetes
Clinical pharmacological properties of mipomersen (Kynamro), a second generation antisense inhibitor of apolipoprotein B
Stratified approaches to the treatment of asthma
Gene doping: gene delivery for olympic victory
Severity of the TGN1412 trial disaster cytokine storm correlated with IL-2 release